Charles Russell Speechlys advises LiDCO Group plc on its £30m share premium account cancellation
Charles Russell Speechlys has advised AIM-listed LiDCO Group plc on the cancellation of its £30.3 million share premium account and the subsequent credit of the sum arising on the cancellation to the company’s profit and loss reserve.
The transaction has enabled the company to eliminate accumulated losses and achieve a positive balance on its profit and loss reserve. Amongst other things, the transaction improves the company’s eligibility for certain grants.
The UK-based group manufactures and supplies invasive, minimally and non-invasive hemodynamic monitoring equipment for high-risk patients in intensive care and surgical settings. The company’s core technologies are patented and recurring revenues are generated for example through monitor usage licences.
Corporate Partner Andrew Collins, who led on the deal, commented: “We were delighted to advise LiDCO Group plc on this transaction which included gaining court approval for the cancellation of the share premium account at court hearings held remotely due to Covid-19. We wish the group every success for the future.”
News & Insights
Charles Russell Speechlys releases H2 2020 deal highlights
Our highlights over the past 6 months are now available.
Haliburton v Chubb: The final say on an arbitrator’s duty of disclosure
We consider some of the key points when appointed arbitrators do not agree on the appointment of the third arbitrator as chairman.
Understanding Rules of Origin under the Brexit Agreement
The UK-EU TCA came into effect on 31st December 2020, what does it mean for importers and exporters? and what does Rules of Origin mean?